CN Patent

CN113350273A — 一种克林霉素磷酸酯注射液及其制备方法

Assigned to Cisen Pharmaceutical Co ltd · Expires 2021-09-07 · 5y expired

What this patent protects

本发明公开了一种新型克林霉素磷酸酯注射液及其制备方法。所述的注射液包括克林霉素磷酸酯、抗氧化剂、络合剂、抑菌剂和pH调节剂。所述的注射液由各组分混合后通过微孔滤膜过滤的方式除菌得到注射用无菌溶液。本发明配制的克林霉素磷酸酯注射液，兼顾了产品稳定性及临床使用的便利性。

USPTO Abstract

本发明公开了一种新型克林霉素磷酸酯注射液及其制备方法。所述的注射液包括克林霉素磷酸酯、抗氧化剂、络合剂、抑菌剂和pH调节剂。所述的注射液由各组分混合后通过微孔滤膜过滤的方式除菌得到注射用无菌溶液。本发明配制的克林霉素磷酸酯注射液，兼顾了产品稳定性及临床使用的便利性。

Drugs covered by this patent

Patent Metadata

Patent number
CN113350273A
Jurisdiction
CN
Classification
—
Expires
2021-09-07
Drug substance claim
No
Drug product claim
No
Assignee
Cisen Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.